Geronimo Sahagun, MD | |
2841 Debarr Road, Suite 50, Anchorage, AK 99508-2932 | |
(907) 276-2811 | |
(907) 276-2810 |
Full Name | Geronimo Sahagun |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 34 Years |
Location | 2841 Debarr Road, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043292865 | NPI | - | NPPES |
MD38571 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 3857 (Alaska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Providence Alaska Medical Center | Anchorage, AK | Hospital |
Alaska Regional Hospital | Anchorage, AK | Hospital |
Fairbanks Memorial Hospital | Fairbanks, AK | Hospital |
Mat-su Regional Medical Center | Palmer, AK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Internal Medicine Associates Llc | 5496745788 | 7 |
News Archive
Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury (AKI), a prevalent and deadly condition.
Researchers have discovered a protein that stimulates secretion of ghrelin, an appetite-stimulating hormone produced in the stomach.
Health Canada today published a Notice of Pre-Consultation in Canada Gazette, Part I, seeking stakeholder feedback on draft Tamper-Resistant Properties of Drugs Regulations.
GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).
› Verified 9 days ago
Entity Name | Internal Medicine Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043294648 PECOS PAC ID: 5496745788 Enrollment ID: O20040518000154 |
News Archive
Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury (AKI), a prevalent and deadly condition.
Researchers have discovered a protein that stimulates secretion of ghrelin, an appetite-stimulating hormone produced in the stomach.
Health Canada today published a Notice of Pre-Consultation in Canada Gazette, Part I, seeking stakeholder feedback on draft Tamper-Resistant Properties of Drugs Regulations.
GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Geronimo Sahagun, MD 2841 Debarr Road, Suite 50, Anchorage, AK 99508-2932 Ph: (907) 276-2811 | Geronimo Sahagun, MD 2841 Debarr Road, Suite 50, Anchorage, AK 99508-2932 Ph: (907) 276-2811 |
News Archive
Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury (AKI), a prevalent and deadly condition.
Researchers have discovered a protein that stimulates secretion of ghrelin, an appetite-stimulating hormone produced in the stomach.
Health Canada today published a Notice of Pre-Consultation in Canada Gazette, Part I, seeking stakeholder feedback on draft Tamper-Resistant Properties of Drugs Regulations.
GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).
› Verified 9 days ago
Andrea Caballero, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3220 Providence Dr Ste E3-080, Anchorage, AK 99508 Phone: 907-375-8785 Fax: 907-375-8788 | |
Daryl M. Mcclendon, M.D., P.C. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3851 Piper Street, Suite U466, Anchorage, AK 99508 Phone: 907-569-1333 Fax: 907-569-1433 | |
Dr. Loretta Leih-sheng Lee, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4001 Dale St, Suite 210, Anchorage, AK 99508 Phone: 907-929-5880 Fax: 907-929-5882 | |
Dr. Richard Merle Farleigh, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 4120 Laurel St, Suite 202, Anchorage, AK 99508 Phone: 907-561-4293 | |
Alexis Leandro Delgado, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4300 B St, Suite 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Dr. Tram Phuong Chu, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Suite B111, Anchorage, AK 99508 Phone: 907-212-7890 Fax: 907-212-2374 |